Market Tracker

09/22 6:05pm ET

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

During the Trading Day
104.71 +0.96 / +0.93%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
104.71 0.00 / 0.00%
 
Volume: 21.4K

Today’s Trading

Previous close103.75
Today’s open103.79
Day’s range102.71 - 105.37
Volume2,697,234
Average volume (3 months)2,090,215
Market cap$24.7B
Dividend yield--
Data as of 3:59pm ET, 09/22/2014

Growth & Valuation

Earnings growth (last year)-296.00%
Earnings growth (this year)-43.90%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)-20.63%
P/E ratioNM
Price/Sales13.79
Price/Book17.88

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC+2.49+1.69%
ZTSZoetis Inc-0.58-1.56%
MYLMylan Inc-0.83-1.75%
ALXNAlexion Pharmaceutic...-1.85-1.15%
Data as of 4:02pm ET, 09/22/2014

Financials

Next reporting dateOctober 27, 2014
EPS forecast (this quarter)-$0.64
Annual revenue (last year)$1.2B
Annual profit (last year)-$445.0M
Net profit margin-36.72%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeff M. Leiden
Chief Financial Officer &
Executive Vice President
Ian F. Smith
Corporate headquarters
Cambridge, Massachusetts

Forecasts